Skip to content

Inovio Pharma under pressure on bearish Citron call

September 23, 2020

COVID-19 vaccine developer Inovio Pharmaceuticals (INO -9.6%) slumps on average volume in apparent response to a post on social media by short seller Citron Research that the stock is heading back to $5 a share, 68% below the current price of $15.47.

Shares peaked at $33.79 on June 26 during the COVID-19 vaccine-stoked rally.

Roth Capital is another bear, believing the candidate INO-4800 has “virtually no chance” of coming out on top of its many competitors.

Muddy Waters is yet another pessimist.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: